1. Home
  2. VIVS vs SOPA Comparison

VIVS vs SOPA Comparison

Compare VIVS & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • SOPA
  • Stock Information
  • Founded
  • VIVS 2007
  • SOPA 2018
  • Country
  • VIVS United States
  • SOPA Singapore
  • Employees
  • VIVS N/A
  • SOPA N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • SOPA EDP Services
  • Sector
  • VIVS Health Care
  • SOPA Technology
  • Exchange
  • VIVS Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • VIVS 3.6M
  • SOPA 3.8M
  • IPO Year
  • VIVS N/A
  • SOPA 2021
  • Fundamental
  • Price
  • VIVS $1.84
  • SOPA $1.43
  • Analyst Decision
  • VIVS
  • SOPA Strong Buy
  • Analyst Count
  • VIVS 0
  • SOPA 1
  • Target Price
  • VIVS N/A
  • SOPA $15.00
  • AVG Volume (30 Days)
  • VIVS 71.5K
  • SOPA 177.7K
  • Earning Date
  • VIVS 06-13-2025
  • SOPA 05-20-2025
  • Dividend Yield
  • VIVS N/A
  • SOPA N/A
  • EPS Growth
  • VIVS N/A
  • SOPA N/A
  • EPS
  • VIVS N/A
  • SOPA N/A
  • Revenue
  • VIVS $144,000.00
  • SOPA $6,731,955.00
  • Revenue This Year
  • VIVS $59.08
  • SOPA N/A
  • Revenue Next Year
  • VIVS $18.24
  • SOPA N/A
  • P/E Ratio
  • VIVS N/A
  • SOPA N/A
  • Revenue Growth
  • VIVS N/A
  • SOPA N/A
  • 52 Week Low
  • VIVS $1.56
  • SOPA $0.64
  • 52 Week High
  • VIVS $21.96
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • VIVS N/A
  • SOPA 61.50
  • Support Level
  • VIVS N/A
  • SOPA $1.18
  • Resistance Level
  • VIVS N/A
  • SOPA $1.67
  • Average True Range (ATR)
  • VIVS 0.00
  • SOPA 0.16
  • MACD
  • VIVS 0.00
  • SOPA -0.00
  • Stochastic Oscillator
  • VIVS 0.00
  • SOPA 60.00

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: